Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Most adult females with acne do not have hormonal imbalances, but some show signs of excess male hormones.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Hirsutism treatments can slow new hair growth, but existing hair needs removal, and eflornithine helps reduce hair growth.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Pesticide exposure may increase the risk of hypospadias in males.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Blocking androgens at birth reduces sexual motivation in male rats.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Early diagnosis and treatment are crucial for complex medical conditions.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Women also use 5α-reductase inhibitors, and their effects differ from men.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Hormonal imbalances in congenital adrenal hyperplasia cause acne.